These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 25349003)

  • 1. Recommendations on screening for prostate cancer with the prostate-specific antigen test.
    Bell N; Connor Gorber S; Shane A; Joffres M; Singh H; Dickinson J; Shaw E; Dunfield L; Tonelli M;
    CMAJ; 2014 Nov; 186(16):1225-34. PubMed ID: 25349003
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial Comment from Dr Stamatiou to Clinical outcomes of prostate cancer patients in Yokosuka City, Japan: A comparative study between cases detected by prostate-specific antigen-based screening in Yokosuka and those detected by other means.
    Stamatiou KN
    Int J Urol; 2015 Aug; 22(8):753. PubMed ID: 26011594
    [No Abstract]   [Full Text] [Related]  

  • 3. Editorial Comment from Dr Izumi to Clinical outcomes of prostate cancer patients in Yokosuka City, Japan: A comparative study between cases detected by prostate-specific antigen-based screening in Yokosuka and those detected by other means.
    Izumi K
    Int J Urol; 2015 Aug; 22(8):752-3. PubMed ID: 26011512
    [No Abstract]   [Full Text] [Related]  

  • 4. Prostate-specific antigen screening for prostate cancer in older men in the United States of America.
    Black A; Berg CD
    Gerontology; 2012; 58(4):331-6. PubMed ID: 22343605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of recommendations against prostate cancer screening with prostate specific antigen].
    Abascal Junquera JM; Fumadó Ciutat L; Francés Comalat A; Cecchini Rosell L
    Med Clin (Barc); 2016 Oct; 147(8):361-365. PubMed ID: 27085747
    [No Abstract]   [Full Text] [Related]  

  • 6. Prostate-specific antigen, prostate cancer screening, and the pathologist: what should be our role?
    Jackson BR
    Arch Pathol Lab Med; 2013 Mar; 137(3):308-9. PubMed ID: 22799565
    [No Abstract]   [Full Text] [Related]  

  • 7. Prostate cancer screening can save lives but it is too early for a national programme, study finds.
    Sayburn A
    BMJ; 2014 Aug; 349():g5055. PubMed ID: 25102993
    [No Abstract]   [Full Text] [Related]  

  • 8. Doing it right: how, not whether, to perform prostate-specific antigen screening.
    Martin NE
    Eur Urol; 2015 Sep; 68(3):361-2. PubMed ID: 25794459
    [No Abstract]   [Full Text] [Related]  

  • 9. Prostate-specific antigen screening can be beneficial to younger and at-risk men.
    Roobol MJ; Bangma CH; Loeb S
    CMAJ; 2013 Jan; 185(1):47-51. PubMed ID: 22566532
    [No Abstract]   [Full Text] [Related]  

  • 10. PSA at 60 may predict risk of death from prostate cancer.
    Rees J
    Practitioner; 2010 Oct; 254(1733):5. PubMed ID: 21141246
    [No Abstract]   [Full Text] [Related]  

  • 11. Reconsidering Prostate Cancer Mortality - The Future of PSA Screening.
    Welch HG; Albertsen PC
    N Engl J Med; 2020 Apr; 382(16):1557-1563. PubMed ID: 32294352
    [No Abstract]   [Full Text] [Related]  

  • 12. Prostate cancer screening with prostate-specific antigen (PSA) test: a clinical practice guideline.
    Tikkinen KAO; Dahm P; Lytvyn L; Heen AF; Vernooij RWM; Siemieniuk RAC; Wheeler R; Vaughan B; Fobuzi AC; Blanker MH; Junod N; Sommer J; Stirnemann J; Yoshimura M; Auer R; MacDonald H; Guyatt G; Vandvik PO; Agoritsas T
    BMJ; 2018 Sep; 362():k3581. PubMed ID: 30185545
    [No Abstract]   [Full Text] [Related]  

  • 13. Alternative prostate cancer screening strategies.
    Labrecque M; Aprikian A
    Ann Intern Med; 2013 May; 158(10):778. PubMed ID: 23689773
    [No Abstract]   [Full Text] [Related]  

  • 14. Correlation between stage shift and differences in mortality in the European Randomised study of Screening for Prostate Cancer (ERSPC).
    Bokhorst LP; Zappa M; Carlsson SV; Kwiatkowski M; Denis L; Paez A; Hugosson J; Moss S; Auvinen A; Roobol MJ
    BJU Int; 2016 Nov; 118(5):677-680. PubMed ID: 27104278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternative prostate cancer screening strategies--in response.
    Gulati R; Etzioni R
    Ann Intern Med; 2013 May; 158(10):778-9. PubMed ID: 23689774
    [No Abstract]   [Full Text] [Related]  

  • 16. Probability, uncertainty, and prostate cancer.
    Concato J
    Ann Intern Med; 2013 Feb; 158(3):211-212. PubMed ID: 23381041
    [No Abstract]   [Full Text] [Related]  

  • 17. Laurence Klotz on the Controversy Surrounding Screening for Prostate Cancer.
    Klotz L
    Oncology (Williston Park); 2016 Aug; 30(8):694, 764. PubMed ID: 27528237
    [No Abstract]   [Full Text] [Related]  

  • 18. Unorganized prostate-specific antigen-based screening for prostate cancer: more harm than benefit. When will we finally start to implement guidelines and risk assessment tools in clinical practice?
    Roobol MJ
    Eur Urol; 2015 Sep; 68(3):363-4. PubMed ID: 25769985
    [No Abstract]   [Full Text] [Related]  

  • 19. Words of wisdom: Re: Comparative effectiveness of alternative prostate-specific antigen-based prostate cancer screening strategies: model estimates of potential benefits and harms.
    Vickers A
    Eur Urol; 2013 Oct; 64(4):682-3. PubMed ID: 23998500
    [No Abstract]   [Full Text] [Related]  

  • 20. Early detection of prostate cancer.
    Taneja SS
    Urol Clin North Am; 2014 May; 41(2):xi-xii. PubMed ID: 24725495
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.